Multispecific Antigen-Binding Molecule With Improved Internalization Characteristics

Patent No. EP3411406 (titled "Multispecific Antigen-Binding Molecule With Improved Internalization Characteristics") was filed by Genmab on Feb 3, 2017. The application was issued on Apr 9, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ELKINGTON AND FIFEJan 9, 2026ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3411406

GENMAB
Application Number
EP17704190A
Filing Date
Feb 3, 2017
Status
Granted And Under Opposition
Mar 7, 2025
Publication Date
Apr 9, 2025